On September 25, 2026, BlackRock, Inc. acquired 1.48 million shares of FOSUN PHARMA (H shares) by way of taking a security interest in shares. The off-exchange transaction was settled with non-cash assets.
Prior to the acquisition, BlackRock, Inc.'s long position in FOSUN PHARMA was 31.96 million shares, representing 5.79%; following the acquisition, the holding changed to 33.45 million shares, with the long position ratio rising to 6.06%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.